Things That Will Blow Your Mind

Conference Context & Theme

• The session explores the convergence of modern technology and neuroscience to address complex brain disorders (tumors, Parkinson's, depression, Alzheimer's) and enhance human functionality.
• The panel focuses on overcoming the biological challenges of "space" (mapping microscopic neural connections) and "time" (controlling millisecond-scale electrical pulses).

Panelist Introductions & Credentials

• Dr. Ed Boyden: Professor at MIT Media Lab and McGovern Institute; leads a synthetic neurobiology group; holds degrees in electrical engineering, computer science, physics, and a PhD in neuroscience.
• Dr. Mary Lou Jepson: Former head of displays at Google and engineering director at Facebook; founder of Open Water; holds a PhD in optical physics from Brown University.
• Brian Johnson: Founder of Braintree (sold to PayPal); committed $100 million to his company Kernel to enhance human intelligence; believes unlocking the brain is history's most significant opportunity.
• Dr. Neil Cassell: Neurosurgeon and founder/chairman of the Focus Ultrasound Foundation; co-chair of Vice President Biden's Cancer Moonshot; aims to treat diseases non-invasively using ultrasound.

Key Technological Advancements & Applications

• Expansion Microscopy (Boyden): Utilizes swellable polymers (similar to baby diapers) to expand brain tissue specimens 100x in volume, enabling nanoscale mapping of molecular circuits.
  • Application: The technique is being used to improve machine learning analysis of cancer biopsies by revealing nanoscale structural changes invisible in unexpanded tissue.
• Optogenetics (Boyden): Uses genetically encoded light-sensitive molecules to activate or deactivate specific neurons with millisecond precision.
  • Therapeutic Strategy: Cognito Therapeutics is commercializing a 40 Hz visual stimulus approach to trigger immune activity that clears amyloid plaques in Alzheimer's models.
• Non-Invasive Brain-Computer Interfaces (Jepson): Open Water is developing wearable, low-cost devices using holographic video and near-infrared light to image deep brain structures.
  • Performance Metrics: Current prototypes achieve 100-micron resolution at 4-inch depth and 5-micron resolution at 1-inch depth, reaching neuronal scale.
  • Cost Strategy: Leverages the existing $400 billion smartphone supply chain (LCD manufacturing) to scale to hundreds of millions of units.
• Focused Ultrasound (Cassell): Uses 1,028 intersecting beams of ultrasound to focus energy on a single point in the brain for non-invasive treatment.
  • Clinical Result: A 64-year-old patient with essential tremor achieved complete symptom remission without incisions, anesthesia, or drugs.
  • Blood-Brain Barrier: Can reversibly open the barrier to deliver high concentrations of chemotherapy or stem cells to specific brain regions.
  • Current Indications: FDA-approved for essential tremor; clinical trials ongoing for Parkinson's, glioblastoma, depression, OCD, epilepsy, and Alzheimer's.

Societal Arguments for Brain Investment

• The "Blind Spot": A survey of 250 smart individuals planning for 2050 failed to identify the brain as a primary priority, despite it being the source of all problem-solving and societal function.
• AI vs. Human Intelligence: Computational intelligence is advancing rapidly without biological constraints, while human cognitive capacity remains "landlocked," creating a widening gap in capability.
• Geopolitical Risk: Nations may begin competing for "human potential" through neurological enhancement, mirroring the early debates over genetic engineering (e.g., CRISPR).
• Complexity Management: Human ability to manage increasing societal and technological complexity is approaching its upper limit, creating systemic risks if cognitive augmentation does not occur.

Forward-Looking Statements & Predictions

• Timeline: Open Water aims to achieve millions of usage minutes within five years, leveraging current manufacturing capabilities.
• Product Evolution: Future capabilities may allow real-time thought communication, accelerated skill acquisition (e.g., learning five times faster), and direct creative output from the brain to machines.
• Ethical Concerns: Mary Lou Jepson highlights the "trepidation" of opening the "last bastion of privacy" (the mind), necessitating responsible definitions of ethical data use before widespread commercialization.
• Nanorobots Skepticism: Dr. Boyden dismisses near-term nanorobots in the brain due to unsolved power source challenges, prioritizing external coupling technologies first.
• Long-term Vision: Dr. Cassell predicts that in 10 years, non-invasive therapies will be standard, eliminating the need for invasive surgery for many conditions.

Strategic Decisions & Investments

• Kernel: Brian Johnson personally funded the $100 million seed capital because venture capitalists and government grants were not yet engaging with the technology.
• Cognito Therapeutics: Formed as a joint venture between Boyden and Li-Wei Tsai to commercialize non-invasive 40 Hz visual therapy for Alzheimer's.
• Focus Ultrasound Foundation: Dr. Cassell focuses on overcoming regulatory, safety, and payer hurdles to gain commercial insurance reimbursement for approved indications.